The state of the art in prediction of breast cancer relapse using cell-free circulating tumor DNA liquid biopsies

Affiliations

¹ Department of Oncology, Skåne University Hospital, Lund, Sweden;; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden;; Lund University Cancer Center, Lund, Sweden.
² Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden;; Lund University Cancer Center, Lund, Sweden;; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden.

Comment

Niklas Loman et al. Ann Transl Med. 2016 Oct.

. 2016 Oct;4(Suppl 1):S68.

doi: 10.21037/atm.2016.10.58.

¹ Department of Oncology, Skåne University Hospital, Lund, Sweden;; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden;; Lund University Cancer Center, Lund, Sweden.
² Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden;; Lund University Cancer Center, Lund, Sweden;; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.
Garcia-Murillas I, Schiavon G, Weigelt B, Ng C, Hrebien S, Cutts RJ, Cheang M, Osin P, Nerurkar A, Kozarewa I, Garrido JA, Dowsett M, Reis-Filho JS, Smith IE, Turner NC. Garcia-Murillas I, et al. Sci Transl Med. 2015 Aug 26;7(302):302ra133. doi: 10.1126/scitranslmed.aab0021. Sci Transl Med. 2015. PMID: 26311728

1. De Mattos-Arruda L, Weigelt B, Cortes J, et al. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle. Ann Oncol 2014;25:1729-35. 10.1093/annonc/mdu239 - DOI - PMC - PubMed
1. Murtaza M, Dawson SJ, Pogrebniak K, et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun 2015;6:8760. 10.1038/ncomms9760 - DOI - PMC - PubMed
1. Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 2008;14:985-90. 10.1038/nm.1789 - DOI - PMC - PubMed
1. Jung K, Fleischhacker M, Rabien A. Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature. Clin Chim Acta 2010;411:1611-24. 10.1016/j.cca.2010.07.032 - DOI - PubMed
1. Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 2014;6:224ra24. 10.1126/scitranslmed.3007094 - DOI - PMC - PubMed